Search Results 961-970 of 3873 for < yeotop3 쩜 com > ◐참가하자◑신포동스파✮신포동마사지☴신포동OP∩신포동건마「신포동풀싸롱✵신포동립카페➱신포동출장
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate, goserelin acetate, leuprolide acetate, anastrozole ...
The purpose of this study is to determine the response rate to PLX-038 in patients with metastatic ovarian, primary peritoneal, and fallopian tube cancers that ...
Below are current clinical trials. 2790 studies in Mayo Clinic Comprehensive Cancer Center — Research (all studies, either open or closed). Filter this list of ...
The drug used for HIPEC will be carboplatin, a Food and Drug Administration (FDA) approved drug for use in ovarian, fallopian tube or primary peritoneal cancer.
This phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IV squamous cell carcinoma of the ...
Title: The Longitudinal Effect of TCF7L2 Genotype on a-cell and ß-cell Function · Title: Outcomes of Standard Versus Non-standard Port Placement for Laparoscopic ...
This is a multi-center, open-label, Phase Ib dose escalation / Phase II study in recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC) ...
Estrogen can cause the growth of breast cancer cells. Hormone therapy, using tamoxifen citrate, may fight breast cancer by blocking the use of estrogen by the ...
Title: A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults with Nonalcoholic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation can make a difference in the future of healthcare. Give now to support Mayo Clinic's research.